Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Yanaprima Hastapersada Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Yanaprima Hastapersada Tbk diperdagangkan di Rp605 (kapitalisasi pasar 404,14 M, volume 24 jam 34,6 rb). Perbedaan utamanya: Yanaprima Hastapersada Tbk jauh lebih besar — sekitar 2,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 34,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | YPAS | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 404,14 M |
Volume | 592,2 rb | 34,6 rb |
Lot | 5,92 rb | 346 |
Perputaran | 147,05 jt | 20,55 jt |
Harga Rata-rata | 248,31 | 593,83 |
Nilai Transaksi | 147,05 jt | 20,55 jt |
Harga Ekuilibrium Indikatif | 254 | 605 |
Volume Ekuilibrium Indikatif | 10 | 70 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Selengkapnya di halaman YPAS →